Search results

4 items
  1. Will Myanmar complete its transition towards an evidence-based approach to drug control?

    Renaud Cachia
    20 March 2018
    Article

    The recent publication of two single pieces of legislation - the amended 1993 Narcotic Drugs and Psychotropic Substances Law and the first National Drug Control Policy - is likely to form the basis of Myanmar’s drug policy for several years to come. What does it mean for the country’s transition towards an evidence-based approach to drug control, and how can the gaps between the two documents be addressed?

  2. အေရွ႕ေတာင္အာရွ မူးယစ္ေဆးဝါးေရးရာမူဝါဒ ျပဳျပင္ေျပာင္းလဲေရးလုပ္ငန္းေတြမွာ ျမန္မာႏိုင္ငံက ဦးေဆာင္ေတာ့မွာလား။

    Renaud Cachia
    12 October 2017
    Article

    ျမန္မာႏုိင္ငံသည္ မူးယစ္ေဆးသုံးစြဲသူမ်ား၏ က်န္းမာေရးကုိ ဦးစားေပးသည့္ ေခတ္မီတုိးတက္ေသာ မူဝါဒမ်ားကုိ အေကာင္အထည္ေဖာ္ေနျခင္းအတြက္ထက္ တရားမဝင္မူးယစ္ေဆး အေျမာက္အမ်ား ထုတ္လုပ္ျခင္း၊ ေရာင္းဝယ္ေဖာက္ကားျခင္းႏွင့္ ဘိန္းျဖဴ (ဟီး႐ုိးအင္း) သုံးစြဲသူဦးေရ ျမင့္မားျခင္းအပါအဝင္ အလြန္ႀကီးမားလွသည့္ မူးယစ္ေဆးျပႆနာမ်ားရွိေနျခင္းအတြက္ ပုိ၍လူသိမ်ားလွပါသည္။ သုိ႔ရာတြင္ မၾကာမီအခ်ိန္အတြင္း ယင္းသုိ႔ေသာ အေျခအေနမွ အေျပာင္းအလဲမ်ားရွိလာႏုိင္ပါသည္။ 

  3. Will Myanmar lead drug policy reform in Southeast Asia?

    Renaud Cachia
    06 September 2017
    Article

    Myanmar is better known for its serious drug problems - including large-scale illicit drugs production and trafficking and high rates of heroin use - than for implementing progressive drug policies that prioritise the health of its population. However, this could change in the near future.

  4. Renaud Cachia

    Profile